Drugmaker AstraZeneca has agreed to pay $50.9 million to settle a class action lawsuit in U.S. court accusing the company of scheming to delay a generic version of its schizophrenia drug Seroquel ...

Augmentation was more effective with quetiapine than lithium for treatment-resistant depression in a pragmatic trial. Quetiapine also improved quality-adjusted life years more than lithium. The ...

Axcend launches the smallest full-stack HPLC system, enabling real-time analysis anywhere with autosampling, in-line PAT, and full-spectrum detection.

Join Lee Polite of Axion Analytical Labs, Inc. as he guides you through the intricacies of chromatography and mass spectrometry using engaging and helpful analogies.

There is a nationwide shortage of some forms of a medication that people who live with schizophrenia and bipolar disorder rely on. Pharmacists have been struggling to get supplies of the 25 ...

Quetiapine hasn’t been approved to treat insomnia by the FDA. However, due to its sedative effects, it’s still sometimes prescribed off-label as a short-term sleep aid.

In this application note, we will look at how the Alliance iS HPLC System has many important elements that will help to achieve a successful method migration.

Intranasal esketamine (Spravato, Janssen) is superior to extended-release quetiapine (Seroquel, AstraZeneca) for treatment-resistant depression, results of a multicenter, head-to-head phase 3 ...

Nasal esketamine spray is more effective than an extended-release antipsychotic, when both are taken in combination with SSRIs and SNRIs, in treatment-resistant depression, a study found.

The doses of esketamine nasal spray and extended-release quetiapine were flexible and accorded with the summary of product characteristics for each agent. 12,17 Details about the dosing and ...